Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 How Did We Get a COVID-19 Vaccine in Less Than 1 Year?

Literature DB >> 33542081

How Did We Get a COVID-19 Vaccine in Less Than 1 Year?

E John Wherry¹, Elizabeth M Jaffee², Nicholas Warren³, Gypsyamber D'Souza⁴, Antoni Ribas.

Abstract

The successful development of COVID-19 vaccines within an unprecedented short time needs to be followed by rapid vaccine uptake, in particular, in high-risk populations such as patients with cancer. It is important for the scientific research community and cancer physicians to convey the knowledge behind the COVID-19 vaccine development and contribute to build the required trust on their use. ©2021 American Association for Cancer Research.

Entities: Chemical

Mesh：

Substances：
COVID-19 Vaccines

Year: 2021 PMID： 33542081 PMCID： PMC8052930 DOI： 10.1158/1078-0432.CCR-21-0079

Source DB: PubMed Journal: Clin Cancer Res ISSN： 1078-0432 Impact factor: 13.801

11 in total

1. Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen.

Authors: Jesper Pallesen; Nianshuang Wang; Kizzmekia S Corbett; Daniel Wrapp; Robert N Kirchdoerfer; Hannah L Turner; Christopher A Cottrell; Michelle M Becker; Lingshu Wang; Wei Shi; Wing-Pui Kong; Erica L Andres; Arminja N Kettenbach; Mark R Denison; James D Chappell; Barney S Graham; Andrew B Ward; Jason S McLellan
Journal: Proc Natl Acad Sci U S A Date: 2017-08-14 Impact factor: 11.205

Review 2. mRNA vaccines - a new era in vaccinology.

Authors: Norbert Pardi; Michael J Hogan; Frederick W Porter; Drew Weissman
Journal: Nat Rev Drug Discov Date: 2018-01-12 Impact factor: 84.694

3. An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma.

Authors: Ugur Sahin; Petra Oehm; Evelyna Derhovanessian; Robert A Jabulowsky; Mathias Vormehr; Maike Gold; Daniel Maurus; Doreen Schwarck-Kokarakis; Andreas N Kuhn; Tana Omokoko; Lena M Kranz; Mustafa Diken; Sebastian Kreiter; Heinrich Haas; Sebastian Attig; Richard Rae; Katarina Cuk; Alexandra Kemmer-Brück; Andrea Breitkreuz; Claudia Tolliver; Janina Caspar; Juliane Quinkhardt; Lisa Hebich; Malte Stein; Alexander Hohberger; Isabel Vogler; Inga Liebig; Stephanie Renken; Julian Sikorski; Melanie Leierer; Verena Müller; Heidrun Mitzel-Rink; Matthias Miederer; Christoph Huber; Stephan Grabbe; Jochen Utikal; Andreas Pinter; Roland Kaufmann; Jessica C Hassel; Carmen Loquai; Özlem Türeci
Journal: Nature Date: 2020-07-29 Impact factor: 49.962

4. At the Crossroads: COVID-19 and Immune-Checkpoint Blockade for Cancer.

Authors: Marina Chiara Garassino; Antoni Ribas
Journal: Cancer Immunol Res Date: 2021-01-15 Impact factor: 12.020

5. Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited.

Authors: Antoni Ribas; Rajarshi Sengupta; Trevan Locke; Sayyed Kaleem Zaidi; Katie M Campbell; John M Carethers; Elizabeth M Jaffee; E John Wherry; Jean-Charles Soria; Gypsyamber D'Souza
Journal: Cancer Discov Date: 2020-12-19 Impact factor: 38.272

Review 6. Simian adenoviruses as vaccine vectors.

Authors: Susan J Morris; Sarah Sebastian; Alexandra J Spencer; Sarah C Gilbert
Journal: Future Virol Date: 2016-09-15 Impact factor: 1.831

7. Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.

Authors: Alicia T Widge; Nadine G Rouphael; Lisa A Jackson; Evan J Anderson; Paul C Roberts; Mamodikoe Makhene; James D Chappell; Mark R Denison; Laura J Stevens; Andrea J Pruijssers; Adrian B McDermott; Britta Flach; Bob C Lin; Nicole A Doria-Rose; Sijy O'Dell; Stephen D Schmidt; Kathleen M Neuzil; Hamilton Bennett; Brett Leav; Mat Makowski; Jim Albert; Kaitlyn Cross; Venkata-Viswanadh Edara; Katharine Floyd; Mehul S Suthar; Wendy Buchanan; Catherine J Luke; Julie E Ledgerwood; John R Mascola; Barney S Graham; John H Beigel
Journal: N Engl J Med Date: 2020-12-03 Impact factor: 91.245

8. A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial.

Authors: Julie E Martin; Mark K Louder; LaSonji A Holman; Ingelise J Gordon; Mary E Enama; Brenda D Larkin; Charla A Andrews; Leatrice Vogel; Richard A Koup; Mario Roederer; Robert T Bailer; Phillip L Gomez; Martha Nason; John R Mascola; Gary J Nabel; Barney S Graham
Journal: Vaccine Date: 2008-09-26 Impact factor: 3.641

9. Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer.

Authors: Victoria A Avanzato; M Jeremiah Matson; Stephanie N Seifert; Rhys Pryce; Brandi N Williamson; Sarah L Anzick; Kent Barbian; Seth D Judson; Elizabeth R Fischer; Craig Martens; Thomas A Bowden; Emmie de Wit; Francis X Riedo; Vincent J Munster
Journal: Cell Date: 2020-11-04 Impact factor: 41.582

10. Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers.

Authors: Jia Luo; Hira Rizvi; Jacklynn V Egger; Isabel R Preeshagul; Jedd D Wolchok; Matthew D Hellmann
Journal: Cancer Discov Date: 2020-05-12 Impact factor: 38.272

7 in total

Review 1. Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer.

Authors: Arielle Elkrief; Julie T Wu; Chinmay Jani; Kyle T Enriquez; Michael Glover; Mansi R Shah; Hira Ghazal Shaikh; Alicia Beeghly-Fadiel; Benjamin French; Sachin R Jhawar; Douglas B Johnson; Rana R McKay; Donna R Rivera; Daniel Y Reuben; Surbhi Shah; Stacey L Tinianov; Donald Cuong Vinh; Sanjay Mishra; Jeremy L Warner
Journal: Cancer Discov Date: 2021-12-10 Impact factor: 38.272

2. Talent Flow Network, the Life Cycle of Firms, and Their Innovations.

Authors: Bo Sun; Ao Ruan; Biyu Peng; Wenzhu Lu
Journal: Front Psychol Date: 2022-05-20

3. Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.

Authors: Henry T Peng; Shawn G Rhind; Andrew Beckett
Journal: JMIR Public Health Surveill Date: 2021-04-07

Review 4. Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?

Authors: Gaurav Joshi; Pobitra Borah; Shweta Thakur; Praveen Sharma; Ramarao Poduri
Journal: Hum Vaccin Immunother Date: 2021-12-02 Impact factor: 3.452